These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2606679)

  • 1. Pharmacokinetic parameters for interspecies scaling using allometric techniques.
    Hayton WL
    Health Phys; 1989; 57 Suppl 1():159-64. PubMed ID: 2606679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine pharmacokinetic scaling among species.
    Owens SM; Hardwick WC; Blackall D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):96-101. PubMed ID: 3612541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine (AZT) in several mammalian species.
    Patel BA; Boudinot FD; Schinazi RF; Gallo JM; Chu CK
    J Pharmacobiodyn; 1990 Mar; 13(3):206-11. PubMed ID: 2115580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interspecies allometric scaling in pharmacokinetics of drugs].
    Sylvia M
    Acta Pharm Hung; 1998 Nov; 68(6):350-4. PubMed ID: 9987199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and allometric scaling of s(+)-ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysis.
    Lepist EI; Jusko WJ
    J Vet Pharmacol Ther; 2004 Aug; 27(4):211-8. PubMed ID: 15305849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allometric scaling for predicting human clearance of bisphenol A.
    Collet SH; Picard-Hagen N; Lacroix MZ; Puel S; Viguié C; Bousquet-Melou A; Toutain PL; Gayrard V
    Toxicol Appl Pharmacol; 2015 May; 284(3):323-9. PubMed ID: 25759244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor.
    Lave T; Saner A; Coassolo P; Brandt R; Schmitt-Hoffmann AH; Chou RC
    J Pharm Pharmacol; 1996 Jun; 48(6):573-7. PubMed ID: 8832489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of allometric scaling principles to predict pharmacokinetic parameters across species.
    Huang Q; Riviere JE
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
    Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
    J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
    Mahmood I
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.
    Huang Q; Gehring R; Tell LA; Li M; Riviere JE
    J Vet Pharmacol Ther; 2015 Jun; 38(3):214-26. PubMed ID: 25333341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic allometric scaling of oligonucleotides.
    Mahmood I
    Nucleic Acid Ther; 2011 Oct; 21(5):315-21. PubMed ID: 21916609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allometric issues in drug development.
    Mahmood I
    J Pharm Sci; 1999 Nov; 88(11):1101-6. PubMed ID: 10564055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
    Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
    Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.
    Hutchaleelaha A; Chow HH; Mayersohn M
    J Pharm Pharmacol; 1997 Feb; 49(2):178-83. PubMed ID: 9055191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.
    Mahmood I
    J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
    Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
    J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.